Literature DB >> 12059995

The economic cost of epilepsy: a review of the literature.

Charles E Begley1, Ettore Beghi.   

Abstract

Economic concerns are increasingly important in health system design, provider payment, and research funding decisions. Cost estimates are needed to provide insight into where the potential opportunities for cost-savings lie and to lay the groundwork for research to determine how to treat the disorder more effectively. The methods used by economists to estimate the direct and indirect costs of epilepsy are reviewed and results from studies in different countries are discussed. General patterns across patients with different types of conditions are reported. Gaps in the literature are identified and future research needs are assessed.

Entities:  

Mesh:

Year:  2002        PMID: 12059995     DOI: 10.1046/j.1528-1157.43.s.4.2.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

1.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

Review 2.  Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Authors:  Kirsten M Fiest; Khara M Sauro; Samuel Wiebe; Scott B Patten; Churl-Su Kwon; Jonathan Dykeman; Tamara Pringsheim; Diane L Lorenzetti; Nathalie Jetté
Journal:  Neurology       Date:  2016-12-16       Impact factor: 9.910

Review 3.  A review of the costs of managing childhood epilepsy.

Authors:  Ettore Beghi; Barbara Frigeni; Massimiliano Beghi; Paola De Compadri; Livio Garattini
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate.

Authors:  Martin J Lan; Peixiong Yuan; Guang Chen; Husseini K Manji
Journal:  J Mol Neurosci       Date:  2008-04-25       Impact factor: 3.444

Review 5.  Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies.

Authors:  Scott D Grosse; Sheila C Dollard; Ismael R Ortega-Sanchez
Journal:  Semin Perinatol       Date:  2021-01-23       Impact factor: 3.300

6.  Economics of epilepsy surgery.

Authors:  Venkatraman Sadanand
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

7.  Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia.

Authors:  Piniel Melkamu; Yaregal Animut; Amare Minyihun; Asmamaw Atnafu; Mezgebu Yitayal
Journal:  Risk Manag Healthc Policy       Date:  2021-06-04

8.  Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release.

Authors:  Mary Ann Werz
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

Review 9.  Childhood febrile seizures: overview and implications.

Authors:  Tonia Jones; Steven J Jacobsen
Journal:  Int J Med Sci       Date:  2007-04-07       Impact factor: 3.738

Review 10.  The economic impact of epilepsy: a systematic review.

Authors:  Katharina Allers; Beverley M Essue; Maree L Hackett; Janani Muhunthan; Craig S Anderson; Kristen Pickles; Franziska Scheibe; Stephen Jan
Journal:  BMC Neurol       Date:  2015-11-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.